2012 annual financial data
Sarepta Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -79.55%.
Operating income was -29,703,000 USD and net income was -121,287,000 USD.
Operating cash flow was -29,694,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 37,329,000 USD
- Operating income
- -29,703,000 USD
- Net income
- -121,287,000 USD
- Operating cash flow
- -29,694,000 USD